Marginal Zone Lymphoma Cohort in Korea

NCT02732236 · clinicaltrials.gov ↗

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, B-Cell, Marginal Zone

Interventions

OTHER: Rituximab

Sponsor

Dong-A University Hospital